ASCO 2024 | Advocating for curative melanoma treatment in older patients

Suthee Rapisuwon • 31 May 2024

ASCO 2024

Melanoma Skin Cancer

Suthee Rapisuwon, MD, Georgetown University, Washington, DC, discusses the importance of providing curative treatment options for older patients with melanoma. The presentation emphasizes considering functional age over chronological age, reviewing data that shows older patients tolerate treatments and achieve similar efficacy as younger patients. The goal is to ensure older patients are not excluded from potentially curative therapies and to improve the community’s approach to offering these treatments. This interview took place during the 2024 American Society of Clinical Oncology (ASCO) Meeting in Chicago, IL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Stock and Other Ownership Interests – Cardiff Oncology
Honoraria – General Dynamics Information Technology (GDIT)
Consulting or Advisory Role – Castle Biosciences; Replimune
Research Funding – AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Pfizer (Inst); Seattle Genetics/Astellas (Inst)